Medicare AdvantageCoverageMedium impact
The Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD) System (Medtronic Inc.) for the treatment of life-threatening ventricular arrhythmias (Retroactively Effective To October 20, 2023)
Independence Blue Cross·Cardiology, Cardiothoracic Surgery, Critical Care·News & Announcements
Effective date
Oct 20, 2023
We identified it
Jun 19, 2026
Summary
Medicare Advantage now covers the Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD) System by Medtronic for treating life-threatening ventricular arrhythmias. This policy change is retroactively effective to October 20, 2023, meaning previously denied claims may now be eligible for reimbursement.
Action Required
Immediately: Billing team should review and resubmit any previously denied claims for Aurora EV-ICD System procedures performed after October 20, 2023. Update billing system to reflect new coverage for this device. Contact Medicare Advantage plans to verify coverage parameters and any prior authorization requirements for future Aurora EV-ICD implantation procedures.